Prostate Cancer
Neurologic Symptoms After 177Lu-Prostate-Specific-Membrane Antigen-617 Therapy: A Single-Center Experience.
August 5, 2024
Incidence and Pitfalls of Adipose Tissue Encountered in Prostatic Transurethral Resections and Related Specimens.
August 5, 2024
LX1 Targets Androgen Receptor Variants and AKR1C3 to overcome Therapy Resistance in Advanced Prostate Cancer.
August 5, 2024
Combining PSMA-PET and PROMISE to re-define disease stage and risk in patients with prostate cancer: a multicentre retrospective study.
August 5, 2024
Incidence of prostate cancer in Medicaid beneficiaries with and without HIV in 2001-2015 in 14 states.
August 2, 2024
Race-Based Screening under the Public Health Ethics Microscope - The Case of Prostate Cancer.
August 1, 2024
Exploring membranous NECTIN-4 expression patterns and enfortumab vedotin response in prostate cancer.
August 1, 2024
Comparison of data fusion strategies for automated prostate lesion detection using mpMRI correlated with whole mount histology.
August 1, 2024
Quantitative PSMA-PET parameters in localized prostate cancer: prognostic and potential predictive value.
August 1, 2024